Recovery Stack (IGF-1 LR3 + BPC-157 + TB-500)
This Recovery stack combines IGF-1 LR3, BPC-157, and TB-500 for tissue repair, recovery support, and muscle regeneration research. The peptide names are included in the title to separate this version from Wolverine and other regeneration-focused stacks.
Recovery Stack Quick Overview
| Peptide | Purpose | Typical Dose |
|---|---|---|
| IGF-1 LR3 | Muscle recovery and anabolic signaling | 30–50 mcg daily |
| BPC-157 | Local tissue repair | 250–500 mcg daily |
| TB-500 | Systemic healing | 2–5 mg weekly |
What Is the Recovery Stack
This stack combines one recovery-focused growth factor analog with two well-known repair-oriented peptides. IGF-1 LR3 is typically discussed for muscle growth and recovery signaling, while BPC-157 is commonly used in localized repair conversations and TB-500 in systemic healing contexts.
Compared with a simpler recovery stack, this version is aimed at people who want repair plus a stronger muscle-regeneration angle. That is why the name includes the exact components rather than using a generic title alone.
How the Stack Works
IGF-1 LR3
- Muscle signaling — is discussed for anabolic and regenerative support
- Post-workout use — is often paired with training recovery goals
- Recovery support — may help frame this stack beyond soft-tissue repair alone
BPC-157
- Localized repair — is often used for tendon, ligament, and injury-site support
- Collagen-related interest — may support soft-tissue remodeling
- Daily structure — is commonly the local-repair backbone of recovery protocols
TB-500
- Systemic repair — supports broader recovery rather than one specific site
- Cell migration — is commonly discussed in tissue-remodeling contexts
- Mobility support — often paired with healing and return-to-training goals
The stack combines local repair, systemic healing, and muscle-regeneration signaling. That makes it a broader recovery concept than BPC-157 or TB-500 alone.
Benefits
- Enhanced recovery and tissue repair support
- Muscle-regeneration positioning
- Soft-tissue and connective-tissue coverage
- Broader support than a two-peptide repair stack
- Recovery planning for training or injury cycles
Typical Protocol
| Week | IGF-1 LR3 | BPC-157 | TB-500 |
|---|---|---|---|
| 1–6 | 30–50 mcg daily | 250–500 mcg daily | 2–5 mg weekly |
| 7–8 | Optional taper | Optional taper | Optional maintenance |
A common pattern is 6–8 weeks, with IGF-1 LR3 usually treated as the shortest-duration component. See the BPC-157 protocol and TB-500 healing-time guide for more context.
Recovery Timeline
- Week 1–2: Inflammation, soreness, and training-readiness are early checkpoints
- Week 3–4: Mobility, tissue tolerance, and recovery speed become more visible
- Week 5–8: Structural repair and muscle-regeneration goals are typically assessed over the longer window
Timelines depend on injury type, workload, sleep, and nutrition. For individual components, see BPC-157 how long to work and TB-500 healing time.
Stack Calculator
FAQs
What is the Recovery stack?
This Recovery stack combines IGF-1 LR3, BPC-157, and TB-500. The page title includes the exact ingredients so it stays distinct from other recovery-oriented stacks like Wolverine or more advanced regeneration protocols.
How is this different from the Wolverine stack?
Wolverine focuses on BPC-157 and TB-500. This Recovery stack adds IGF-1 LR3, which shifts it toward recovery plus muscle-regeneration and anabolic signaling discussion.
Who looks at a Recovery stack like this?
People usually look at this type of stack for injury recovery, soft-tissue support, post-training repair, and preserving or rebuilding muscle while healing.
How long does a Recovery stack cycle last?
A common range is 6–8 weeks, though timing varies by injury severity, training load, and which compounds are emphasized most strongly.
Is the exact three-part stack well studied in humans?
No. The full three-part stack is not backed by strong direct human trial data. Most discussion is extrapolated from individual compound literature and practice-based stacking logic.
Sources
- The therapeutic potential of IGF-I in skeletal muscle repair (PubMed)
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth (PubMed)
- Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation (PubMed)
- The actin binding site on thymosin beta4 promotes angiogenesis (PubMed)
- The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients (PubMed)
Internal linking
Related Protocols
Related Calculators
For educational and research purposes only. Not medical advice. Consult a licensed healthcare professional for personal guidance.